The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Liu, Hui ^a   Kato, Yukinari ^a   Erzinger, Stephanie A ^a   Kiriakova, Galina M ^a   Qian, Yongzhen ^b   Palmieri, Diane ^b   Steeg, Patricia S ^b   Price, Janet E ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Brain metastasis; Breast cancer; EGFR; MMP 1; TGF

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INTERSTITIAL COLLAGENASE; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METASTASIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PRIMARY TUMOR; TUMOR XENOGRAFT;

ANIMALS; BRAIN; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 1; MICE; MICE, NUDE; NEOPLASM METASTASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSPLANTATION, HETEROLOGOUS;

EID: 84870482124     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-583     Document Type: Article

References (53)

1. Weil RJ, Palmieri DC, Bronder JL, et al. Breast cancer metastasis to the central nervous system. Am J Pathol 2005, 167:913-920. 10.1016/S0002-9440(10)61180-7, 1603675, 16192626.
2. Lin NU, Winer EP. Brain metastases: the HER2 paradigm. Clin Cancer Res 2007, 13:1648-1655. 10.1158/1078-0432.CCR-06-2478, 17363517.
3. Palmieri D, Fitzgerald D, Shreeve SM, et al. Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res 2009, 7:1438-1445. 10.1158/1541-7786.MCR-09-0234, 2746883, 19723875.
4. Bos PD, Zhang XH, Nadal C, et al. Genes that mediate breast cancer metastasis to the brain. Nature 2009, 459:1005-1009. 10.1038/nature08021, 2698953, 19421193.
5. Fidler IJ, Balasubramanian K, Lin Q, et al. The brain microenvironment and cancer metastasis. Mol Cells 2010, 30:93-98. 10.1007/s10059-010-0133-9, 20799011.
6. Kim LS, Huang S, Lu W, et al. Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice. Clin Exp Metastasis 2004, 21:107-118.
7. Yoneda T, Williams PJ, Hiraga T, et al. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 2001, 16:1486-1495. 10.1359/jbmr.2001.16.8.1486, 11499871.
8. Ala-aho R, Kahari VM. Collagenases in cancer. Biochimie 2005, 87:273-286. 10.1016/j.biochi.2004.12.009, 15781314.
9. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996, 2:461-462. 10.1038/nm0496-461, 8597958.
10. Murray GI, Duncan ME, O'Neil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 1998, 185:256-261. 10.1002/(SICI)1096-9896(199807)185:3<256::AID-PATH115>3.0.CO;2-A, 9771478.
11. Nakopoulou L, Giannopoulou I, Gakiopoulou H, et al. Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features. Hum Pathol 1999, 30:436-442. 10.1016/S0046-8177(99)90120-X, 10208466.
12. Ito T, Ito M, Shiozawa J, et al. Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor. Mod Pathol 1999, 12:669-674.
13. McGowan PM, Duffy MJ. Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database. Ann Oncol 2008, 19:1566-1572. 10.1093/annonc/mdn180, 18503039.
14. Poola I, DeWitty RL, Marshalleck JJ, et al. Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis. Nat Med 2005, 11:481-483. 10.1038/nm1243, 15864312.
15. Pardo A, Selman M. MMP-1: the elder of the family. Int J Biochem Cell Biol 2005, 37:283-288. 10.1016/j.biocel.2004.06.017, 15474975.
16. Pei D. Matrix metalloproteinases target protease-activated receptors on the tumor cell surface. Cancer Cell 2005, 7:207-208. 10.1016/j.ccr.2005.02.011, 15766657.
17. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol 2001, 13:534-540. 10.1016/S0955-0674(00)00248-9, 11544020.
18. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2:161-174. 10.1038/nrc745, 11990853.
19. Iida J, McCarthy JB. Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-beta. Melanoma Res 2007, 17:205-213. 10.1097/CMR.0b013e3282a660ad, 17625450.
20. Hotary KB, Allen ED, Brooks PC, et al. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003, 114:33-45. 10.1016/S0092-8674(03)00513-0, 12859896.
21. Blackburn JS, Brinckerhoff CE. Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis. Am J Pathol 2008, 173:1736-1746. 10.2353/ajpath.2008.080512, 2626385, 18988801.
22. Lu X, Wang Q, Hu G, et al. ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev 2009, 23:1882-1894. 10.1101/gad.1824809, 2725946, 19608765.
23. Lev DC, Kiriakova G, Price JE. Selection of more aggressive variants of the gI101A human breast cancer cell line: a model for analyzing the metastatic phenotype of breast cancer. Clin Exp Metastasis 2003, 20:515-523. 10.1023/A:1025837631179, 14598885.
24. Palmieri D, Bronder JL, Herring JM, et al. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res 2007, 67:4190-4198. 10.1158/0008-5472.CAN-06-3316, 17483330.
25. Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002, 2:657-672. 10.1038/nrc884, 12209155.
26. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 2007, 8:221-233. 10.1038/nrm2125, 2760082, 17318226.
27. Huang SHF-J, Chou P-C, Sawaya R, Steeg PS. Inhibition of signal transducer and activator of transcription 3 activation suppresses the brain metastases of MDA-MB-231-BR cells in nude mice. Era of Hope DOD-BCPR meeting proceeding book 2008, page 273.
28. Tsareva SA, Moriggl R, Corvinus FM, et al. Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 2007, 9:279-291. 10.1593/neo.06820, 1854849, 17460772.
29. Milde-Langosch K, Roder H, Andritzky B, et al. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas. Breast Cancer Res Treat 2004, 86:139-152. 10.1023/B:BREA.0000032982.49024.71, 15319566.
30. Wyatt CA, Geoghegan JC, Brinckerhoff CE. Short hairpin RNA-mediated inhibition of matrix metalloproteinase-1 in MDA-231 cells: effects on matrix destruction and tumor growth. Cancer Res 2005, 65:11101-11108. 10.1158/0008-5472.CAN-05-2446, 16322260.
31. Eck SM, Hoopes PJ, Petrella BL, et al. Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model. Breast Cancer Res Treat 2009, 116:79-90. 10.1007/s10549-008-0085-3, 18597171.
32. Heyn C, Ronald JA, Ramadan SS, et al. In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn Reson Med 2006, 56:1001-1010. 10.1002/mrm.21029, 17029229.
33. Fitzgerald DP, Palmieri D, Hua E, et al. Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization. Clin Exp Metastasis 2008, 25:799-810. 10.1007/s10585-008-9193-z, 2679391, 18649117.
34. De Luca A, Carotenuto A, Rachiglio A, et al. The role of the EGFR signaling in tumor microenvironment. J Cell Physiol 2008, 214:559-567. 10.1002/jcp.21260, 17894407.
35. Ritter CA, Arteaga CL. The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors. Semin Oncol 2003, 30:3-11.
36. Zhang L, Sullivan P, Suyama J, Marchetti D. Epidermal growth factor-induced heparanase nucleolar localization augments DNA topoisomerase I activity in brain metastatic breast cancer. Mol Cancer Res 2010, 8:278-290. 10.1158/1541-7786.MCR-09-0375, 20164500.
37. Gril B, Palmieri D, Bronder JL, et al. Effect of lapatinib on the outgrowth of metastatic breast cancer cells to the brain. J Natl Cancer Inst 2008, 100:1092-1103. 10.1093/jnci/djn216, 2575427,2575427, 18664652.
38. Leker RR, Toth ZE, Shahar T, et al. Transforming growth factor alpha induces angiogenesis and neurogenesis following stroke. Neuroscience 2009, 163:233-243. 10.1016/j.neuroscience.2009.05.050, 2747305, 19481589.
39. Sharif A, Legendre P, Prevot V, et al. Transforming growth factor alpha promotes sequential conversion of mature astrocytes into neural progenitors and stem cells. Oncogene 2007, 26:2695-2706. 10.1038/sj.onc.1210071, 17057735.
40. White RE, Yin FQ, Jakeman LB. TGF-alpha increases astrocyte invasion and promotes axonal growth into the lesion following spinal cord injury in mice. Exp Neurol 2008, 214:10-24. 10.1016/j.expneurol.2008.06.012, 2895965, 18647603.
41. Lorger M, Felding-Habermann B. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am J Pathol 2010, 176:2958-2971. 10.2353/ajpath.2010.090838, 2877856, 20382702.
42. Lin Q, Balasubramanian K, Fan D, et al. Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels. Neoplasia 2010, 12:748-754. 2933695, 20824051.
43. Zhang M, Olsson Y. Hematogenous metastases of the human brain-characteristics of peritumoral brain changes: a review. J Neurooncol 1997, 35:81-89. 10.1023/A:1005799805335, 9266444.
44. Marchetti D, Li J, Shen R. Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase. Cancer Res 2000, 60:4767-4770.
45. Sierra A, Price JE, Garcia-Ramirez M, et al. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells. Lab Invest 1997, 77:357-368.
46. Trivedi V, Boire A, Tchernychev B, et al. Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site. Cell 2009, 137:332-343. 10.1016/j.cell.2009.02.018, 2807741, 19379698.
47. Yang E, Boire A, Agarwal A, et al. Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis. Cancer Res 2009, 69:6223-6231. 10.1158/0008-5472.CAN-09-0187, 2733168, 19622769.
48. Kim YV, Di Cello F, Hillaire CS, Kim KS. Differential Ca2+ signaling by thrombin and protease-activated receptor-1-activating peptide in human brain microvascular endothelial cells. Am J Physiol Cell Physiol 2004, 286:C31-42.
49. Nicole O, Goldshmidt A, Hamill CE, et al. Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. J Neurosci 2005, 25:4319-4329. 10.1523/JNEUROSCI.5200-04.2005, 15858058.
50. Shibue T, Weinberg RA. Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Semin Cancer Biol 2011, 21:99-106. 10.1016/j.semcancer.2010.12.003, 21145969.
51. Talmadge JE, Fidler IJ. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 2010, 70:5649-5669. 10.1158/0008-5472.CAN-10-1040, 20610625.
52. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000, 18:1135-1149.
53. Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 2009, 27:5287-5297. 10.1200/JCO.2009.23.5556, 2773480, 19738110.